Back
Perspective Therapeutics 10K Form
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.49
Seasonality Move:
34.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CATX News And Ratings
See the #1 stock for the next 7 days that we like better than CATX
CATX Financial Statistics
Sales & Book Value
Annual Sales: | $3.55M |
---|---|
Cash Flow: | $-26.35M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.86 |
Price / Book: | 0.71 |
Profitability
EPS (TTM): | -1.46000 |
---|---|
Net Income (TTM): | $-63.79M |
Gross Margin: | $817K |
Return on Equity: | 0% |
Return on Assets: | 0% |
Perspective Therapeutics Earnings Forecast
Key Perspective Therapeutics Financial Ratios
Perspective Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | CATX |
Website: | perspectivetherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.